Hongming Huang

机构：Shenyang Agricultural University, Guangdong University of Technology, Shanghai Jiao Tong University, Nantong University, Hubei University of Chinese Medicine, Renji Hospital, Affiliated Hospital of Nantong University, Guangdong Polytechnic Normal University, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Southern Medical University, Fuzhou University · ORCID：0000-0001-9695-4674

发表论文 76 篇 · 总被引 897 次 · h-index 17

代表论文

• Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial (2024 · Nature Communications · 被引 110)
• Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma (2023 · Thrombosis Journal · 被引 11)
• Senolytic treatment alleviates cochlear senescence and delays age-related hearing loss in C57BL/6J mice (2025 · Phytomedicine · 被引 10)
• SAE1 promotes tumor cell malignancy via SUMOylation and liquid–liquid phase separation facilitated nuclear export of p27 (2025 · Acta Pharmaceutica Sinica B · 被引 10)
• Highly efficient gene knockout system in the maize pathogen Colletotrichum graminicola using Agrobacterium tumefaciens-mediated transformation (ATMT) (2023 · Journal of Microbiological Methods · 被引 7)
• Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapy (2023 · Clinical and Experimental Medicine · 被引 6)